 |
|
|
|
|
|||
|
CASRO's 325+ member companies and their 32,000 employees, all of whom are afforded membership benefits, represent nearly $8 billion in global annual revenue–about 85% of the US research industry and 30% of the global research industry. All CASRO members must adhere to the CASRO Code of Standards and Ethics, the enforceable standard for research businesses for more than 30 years.
|
|
||||||
 |
|
||||||
CASRO Launches Internship Program - Seeks to Match Qualified College Students With Research Companies
CASRO’s Career Development Committee is pleased to announce the formation of an Internship/Co-op Program, which seeks to match qualified, motivated college students with research companies offering rewarding internship opportunities. Participating companies will be provided with helpful templates and guidelines. The inclusion of an evaluation mechanism for both employers and interns will help gauge the overall success of the program and determine areas for improvement. Best of all, companies will have access to a nationwide pool of talented workers. CASRO member companies and interested colleges are encouraged to join via the forms accessible on the webpage below. |
 |
 CASRO NewsAuthors, Client-Side Researchers Highlight 2011 Annual Conference Sessions CASRO Announces Social Media Research Guidelines CASRO Announces First Research-Specific Liability Insurance Program District of Columbia Excludes MR Physician Payments from Reporting Requirement CASRO and ESOMAR Partner in the Development of Online Sample Quality Standard CASRO, ESOMAR Outline Position on "Do Not Track" MEMBERS ONLYLegal Memo: FTC Proposes Revisions to the Children's Online Privacy Protection Act Legal Memo: DC Publishes Pharmaceutical Reporting Regulations Legislative Tracking Report (January 2012) State of the Business Survey Results (Third Quarter 2011) Model Sweepstakes Affidavit Now Available Maine Repeals Pharmaceutical Gift Reporting Statute Upcoming Events
March 1 - 2, 2012
2012 Online Research Conference Las Vegas, Nevada
|
|
||||
|
|
||||||
|
|
||||||
